Pharmaceuticals Policy 2025-2035

Driving Global Leadership in Pharmaceutical Innovation and Manufacturing

Andheri, a leading industrial powerhouse in India, is strategically poised to become a global hub for pharmaceutical innovation, research, and manufacturing. The Andheri Pharmaceuticals Policy 2024 leverages the state’s robust industrial foundation, skilled workforce, and advanced infrastructure to attract investments, drive innovation, and ensure sustainable growth in the pharmaceutical industry.

The “” initiative aims to establish the state as a premier destination for pharmaceutical investments by promoting eco-friendly manufacturing and cutting-edge research. The policy emphasizes building a strong ecosystem that supports pharmaceutical clusters, R&D facilities, and high-tech manufacturing units, solidifying Andheri’s position as a global leader in the pharmaceutical sector.

Vision for 2030

Andheri as a Global Pharmaceutical Leader

By 2030, envisions transforming the state into India’s top destination for pharmaceutical investments, with the following ambitious goals:

  • Positioning Andheri as the preferred choice for domestic and global pharmaceutical companies, targeting ₹1 lakh crore in investments.
  • Developing over 15 pharmaceutical parks and clusters equipped with world-class infrastructure, dedicated industrial feeders, and 24×7 power supply to foster high-quality manufacturing.
  • Generating more than 2 lakh direct and indirect jobs, with a focus on empowering women, youth, and rural communities.
  • Promoting sustainable manufacturing by incentivizing zero-effluent discharge technologies and other eco-friendly practices.

Advancing pharmaceutical R&D and innovation by fostering collaborations among academic institutions, research centers, and industry leaders to accelerate drug discovery, clinical research, and biosimilar development.

Mission

Building Andheri’s Pharmaceutical Ecosystem

is committed to building a globally competitive pharmaceutical ecosystem that fuels economic growth, champions innovation, and promotes sustainable development. The Andheri Pharmaceuticals Policy 2024 is guided by the following core missions:
  • Attract large-scale investments in pharmaceutical manufacturing, research, and infrastructure by offering industry-leading incentives and ensuring ease of doing business.
  • Promote sustainable and eco-friendly manufacturing practices, ensuring that Andheri becomes a leader in green pharmaceutical production.
  • Foster research and innovation in life sciences by establishing dedicated pharmaceutical R&D hubs, supporting the development of new drugs, biosimilars, and vaccines.
  • Create employment opportunities by upskilling the workforce and providing training in high-tech pharmaceutical manufacturing and quality control.
  • Enhance Andheri’s global competitiveness in pharmaceuticals by building export promotion zones and facilitating market access to international pharmaceutical markets.

Ease of Doing Business

Streamlined Approvals and Regulatory Support

Andheri is dedicated to facilitating a smooth business environment for pharmaceutical investors and manufacturers. The state will introduce a Single Window Clearance System to simplify the approval process for pharmaceutical projects. Additionally, companies will benefit from self-certification under labor laws, minimizing regulatory hurdles and ensuring efficient and timely project execution.

Andheri Leading India’s Pharmaceutical Revolution by 2030

The Andheri Pharmaceuticals Policy 2024 is a visionary and strategic initiative aimed at establishing Andheri as a global leader in pharmaceutical innovation and sustainable manufacturing. By attracting investments, driving R&D, and promoting eco-friendly practices, the state will spearhead India’s rise as a prominent global pharmaceutical hub.

Pharmaceuticals Policy 2025-2035

invites global pharmaceutical companies, researchers, and innovators to join this transformative journey and contribute to building a sustainable, innovative, and globally competitive pharmaceutical ecosystem.

Stay Updated with Us

About

The is a Public Benefit Corporation (PBC) with a mission to establish Andheri as a key player in international economic collaboration, focusing on strategic partnerships with nations like USA, Europe, Australia, African Union, KSA, China, India, Qatar, Saudi Arabia, Türkiye, and the UAE across vital sectors such as energy, technology, agriculture, and finance. Our goal is to integrate lessons from successful global economic models, adopting best practices to ensure sustainable and inclusive growth. We aim to enhance economic prosperity and diversification, contribute to societal progress, and promote sustainable economic practices. By leveraging Andheri’s unique position, strives to drive substantial economic growth, spur innovation, and solidify Andheri’s stature in the international economic arena, resonating with the government’s vision of a technologically advanced and interconnected economy.

Contact

Newsletter

Please enable JavaScript in your browser to complete this form.

Copyright © 2025 All Rights Reserved. Andheri Chamber of Commerce and Industry powered by WSSH Australia